Viridian Therapeutics, Inc. · NASDAQ:VRDN
Venrock Healthcare Capital Partners III, L.P.'s stake in Viridian Therapeutics, Inc. fell to 4.50% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Venrock Healthcare Capital Partners III, L.P.'s stake in Viridian Therapeutics, Inc. fell to 4.50%, 3,575,309 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 3,575,309
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 4.50% | 3,575,309 |
| VHCP Co-Investment Holdings III, LLC | 4.50% | 3,575,309 |
| Venrock Healthcare Capital Partners EG, L.P. | 4.50% | 3,575,309 |
| VHCP Management III, LLC | 4.50% | 3,575,309 |
| VHCP Management EG, LLC | 4.50% | 3,575,309 |
| Nimish Shah | 4.50% | 3,575,309 |
| Bong Y Koh | 4.50% | 3,575,309 |
Source
Related
- Viridian Therapeutics, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Viridian Therapeutics, Inc. shareholders
- Form 4 · Tousignant Jennifer · Aug 20, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Aug 20, 2026
- Form 4 · Tripuraneni Radhika · Aug 18, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Aug 14, 2026